Compare Canopy Growth Corp (CGC) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs Merck & Co., Inc. — how do they compare? Canopy Growth Corp trades at $0.97 (market cap $398.46M), while Merck & Co., Inc. trades at $123.33 (market cap $298.31B). The key difference: Merck & Co., Inc. is far larger — about 748.7× Canopy Growth Corp's market cap, and Merck & Co., Inc. pays a 2.82% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | MRK | |
|---|---|---|
Market Cap | $398.46M | $298.31B |
Sector | Health | Health |
52-Week High | $1.92 | $129.52 |
52-Week Low | $0.86 | $77.60 |
Enterprise Value | $337.90M | $341.72B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Merck (MRK) trades at $123.45, down 0.47% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings have consistently beaten expectations, including Q1 2026, and the company is actively expanding its oncology pipeline through acquisitions like Terns Pharmaceuticals. Revenue reached $65.01B in 2025 with a net income margin of 28.07%, though 2026 forecasts show a decline in profitability.
The outlook remains positive with a consensus price target of $137.30, offering ~11% upside. Key risks include increased debt levels, competitive pressures in oncology, and potential regulatory hurdles from acquisitions. Institutional buying activity supports confidence, but investors should monitor execution on growth initiatives and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
